title: Response to "Rosiglitazone no longer recommended".
authors.forename: Ellen
authors.initials: E
authors.lastname: Strahlman
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone